Jun Justin Luo Sells 70,440 Shares of 111 (NASDAQ:YI) Stock

111, Inc. Sponsored ADR (NASDAQ:YI) Director Jun Justin Luo sold 70,440 shares of the business’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $0.25, for a total value of $17,610.00. Following the transaction, the director directly owned 710,551 shares of the company’s stock, valued at approximately $177,637.75. The trade was a 9.02% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jun Justin Luo also recently made the following trade(s):

• On Tuesday, May 26th, Jun Justin Luo sold 29,280 shares of 111 stock. The stock was sold at an average price of $0.27, for a total value of $7,905.60.

111 Trading Down 3.8%

Shares of NASDAQ YI opened at $5.26 on Friday. The company has a market cap of $46.24 million, a price-to-earnings ratio of -5.26 and a beta of 0.66. The stock has a 50-day moving average price of $6.26 and a two-hundred day moving average price of $5.58. 111, Inc. Sponsored ADR has a 12 month low of $2.48 and a 12 month high of $11.17.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded 111 from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, May 21st. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has an average rating of “Sell”.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.